Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062709

Lynch Ryan sold 240 shares at $17.90 ($4,296)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lynch Ryan

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-16 Sale : show line 1 in the form 10b5-1 −240 $17.90 $4,296 13,631 D
Open-market sales · 240 sh · avg $17.90 · $4,296
Loading xslF345X06/wk-form4_1789761811.xml…